LENALIDOMIDE MONOTHERAPY AS SALVAGE TREATMENT FOR RECURRENT PRIMARY CNS LYMPHOMA

被引：93

作者：

Houillier, Caroline ^{[1
,2
,3
,5
]}

Choquet, Sylvain ^{[1
,3
,5
]}

Touitou, Valerie ^{[1
,3
,5
]}

Martin-Duverneuil, Nadine ^{[1
,3
,5
]}

Navarro, Soledad ^{[1
,3
,5
]}

Mokhtari, Karima ^{[1
,2
,3
,5
]}

Soussain, Carole ^{[4
,5
]}

Hoang-Xuan, Khe ^{[1
,2
,3
,5
]}

机构：

[1] Grp Hosp Pitie Salpetriere, AP HP, F-75634 Paris, France

[2] Grp Hosp Pitie Salpetriere, Investissements Avenir ANR IAIHU 06 10, ICM, F-75634 Paris, France

[3] Sorbonne Univ, Univ Paris 06, UM 75, ICM, Paris, France

[4] Hop Rene Huguenin, Inst Curie, St Cloud, France

[5] LOC French Natl Network, Paris, France

来源：

NEUROLOGY | 2015年 / 84卷 / 03期

关键词：

B-CELL LYMPHOMA; TRIAL;

D O I：

10.1212/WNL.0000000000001158

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：325 / 326

页数：2

共 7 条

[1] Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma [J].

Abrey, LE ;

Batchelor, TT ;

Ferreri, AJM ;

Gospodarowicz, M ;

Pulczynski, EJ ;

Zucca, E ;

Smith, JR ;

Korfel, A ;

Soussain, C ;

DeAngelis, LM ;

Neuwelt, EA ;

O'Neill, BP ;

Thiel, E ;

Shenkier, T ;

Graus, F ;

van den Bent, M ;

Seymour, JF ;

Poortmans, P ;

Armitage, JO ;

Cavalli, F .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5034-5043

[2] Salvage therapy with bendamustine for methotrexate refractory recurrent primary CNS lymphoma: a retrospective case series [J].

Chamberlain, Marc C. .

JOURNAL OF NEURO-ONCOLOGY, 2014, 118 (01) :155-162

[3] Lenalidomide for aggressive B-cell lymphoma involving the central nervous system? [J].

Cox, Maria Christina ;

Mannino, Giuseppe ;

Lionetto, Luana ;

Naso, Virginia ;

Simmaco, Maurizio ;

Spiriti, Maria Antonietta Aloe .

AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (11) :957-957

[4] Regression of Refractory Intraocular Large B-Cell Lymphoma With Lenalidomide Monotherapy [J].

Rubenstein, James L. ;

Treseler, Patrick A. ;

Stewart, Paul J. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (20) :E595-E597

[5] An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma [J].

Witzig, T. E. ;

Vose, J. M. ;

Zinzani, P. L. ;

Reeder, C. B. ;

Buckstein, R. ;

Polikoff, J. A. ;

Bouabdallah, R. ;

Haioun, C. ;

Tilly, H. ;

Guo, P. ;

Pietronigro, D. ;

Ervin-Haynes, A. L. ;

Czuczman, M. S. .

ANNALS OF ONCOLOGY, 2011, 22 (07) :1622-1627

[6] Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation [J].

Zhu, Dan ;

Corral, Laura G. ;

Fleming, Yuedi W. ;

Stein, Bernd .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (12) :1849-1859

[7] Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial [J].

Zinzani, Pier Luigi ;

Pellegrini, Cinzia ;

Gandolfi, Letizia ;

Stefoni, Vittorio ;

Quirini, Federica ;

Derenzini, Enrico ;

Broccoli, Alessandro ;

Argnani, Lisa ;

Pileri, Stefano ;

Baccarani, Michele .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06) :462-466

← 1 →